Liposomal anthracycline chemotherapy and the risk of second malignancies in patients with Kaposi's sarcoma (KS).
about
Liposomal anthracycline chemotherapy and the risk of second malignancies in patients with Kaposi's sarcoma (KS).
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Liposomal anthracycline chemot ...... ts with Kaposi's sarcoma (KS).
@en
Liposomal anthracycline chemot ...... patients with Kaposi's sarcoma
@nl
type
label
Liposomal anthracycline chemot ...... ts with Kaposi's sarcoma (KS).
@en
Liposomal anthracycline chemot ...... patients with Kaposi's sarcoma
@nl
prefLabel
Liposomal anthracycline chemot ...... ts with Kaposi's sarcoma (KS).
@en
Liposomal anthracycline chemot ...... patients with Kaposi's sarcoma
@nl
P2093
P2860
P1476
Liposomal anthracycline chemot ...... ts with Kaposi's sarcoma (KS).
@en
P2093
P Papanastasopoulos
P2860
P2888
P304
P356
10.1007/S00280-014-2538-1
P50
P577
2014-07-24T00:00:00Z
P6179
1046309987